Stryker raises 2025 outlook amid 17.3% medical surgery and neurotechnology unit rise
Stryker’s vascular segment reached $498m in Q2 2025, more than doubling its financial performance in Q2 2024.
01 August 2025
Stryker’s vascular segment reached $498m in Q2 2025, more than doubling its financial performance in Q2 2024.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.